These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 9081339)
1. [Locally advanced carcinoma of the cervix (distal II, Barrel-shaped and III) treated by irradiation alone: impact of individual treatment planning on results, sequelae and complications]. Barillot I; Horiot JC; Maingon P; Bône-Lepinoy MC; D'Hombres A; Comte J Bull Cancer Radiother; 1996; 83(4):364-9. PubMed ID: 9081339 [No Abstract] [Full Text] [Related]
2. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. Eifel PJ; Winter K; Morris M; Levenback C; Grigsby PW; Cooper J; Rotman M; Gershenson D; Mutch DG J Clin Oncol; 2004 Mar; 22(5):872-80. PubMed ID: 14990643 [TBL] [Abstract][Full Text] [Related]
3. High-dose rate brachytherapy using inverse planning simulated annealing for locoregionally advanced cervical cancer: a clinical report with 2-year follow-up. Kim DH; Wang-Chesebro A; Weinberg V; Pouliot J; Chen LM; Speight J; Littell R; Hsu IC Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1329-34. PubMed ID: 19409728 [TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up results of irradiation alone or combined with surgery in stage I-IV carcinoma of the uterine cervix. Reinartz G; Bartsch S; Willich N Zentralbl Gynakol; 2000; 122(6):318-23. PubMed ID: 10904995 [TBL] [Abstract][Full Text] [Related]
5. Californium-252 (252Cf) versus conventional gamma radiation in the brachytherapy of advanced cervical carcinoma long-term treatment results of a randomized study. Tacev T; Ptácková B; Strnad V Strahlenther Onkol; 2003 Jun; 179(6):377-84. PubMed ID: 12789463 [TBL] [Abstract][Full Text] [Related]
7. [Radiotherapy and brachytherapy in advanced cancers of the cervix]. Haie-Meder C; Lartigau E; Gerbaulet A Bull Cancer Radiother; 1996; 83(4):360-3. PubMed ID: 9081338 [No Abstract] [Full Text] [Related]
8. Radiation therapy alone for adenocarcinoma of the uterine cervix. Nakano T; Arai T; Morita S; Oka K Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1331-6. PubMed ID: 7635772 [TBL] [Abstract][Full Text] [Related]
9. Correlation between the treated volume, the GTV and the CTV at the time of brachytherapy and the histopathologic findings in 33 patients with operable cervix carcinoma. Muschitz S; Petrow P; Briot E; Petit C; De Crevoisier R; Duvillard P; Morice P; Haie-Meder C Radiother Oncol; 2004 Nov; 73(2):187-94. PubMed ID: 15542166 [TBL] [Abstract][Full Text] [Related]
10. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series. Ferrigno R; Nishimoto IN; Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1108-16. PubMed ID: 15990016 [TBL] [Abstract][Full Text] [Related]
11. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience. Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997 [TBL] [Abstract][Full Text] [Related]
12. Comparative study of LDR (Manchester system) and HDR image-guided conformal brachytherapy of cervical cancer: patterns of failure, late complications, and survival. Narayan K; van Dyk S; Bernshaw D; Rajasooriyar C; Kondalsamy-Chennakesavan S Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1529-35. PubMed ID: 19473780 [TBL] [Abstract][Full Text] [Related]
13. Results of concomitant chemoradiation for cervical cancer using high dose rate intracavitary brachytherapy: study of JROSG (Japan Radiation Oncology Study Group). Sakata K; Sakurai H; Suzuki Y; Katoh S; Ohno T; Toita T; Kataoka M; Tanaka E; Kaneyasu Y; Uno T; Harima Y; Nakano T; Acta Oncol; 2008; 47(3):434-41. PubMed ID: 18348003 [TBL] [Abstract][Full Text] [Related]
14. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Pötter R; Dimopoulos J; Georg P; Lang S; Waldhäusl C; Wachter-Gerstner N; Weitmann H; Reinthaller A; Knocke TH; Wachter S; Kirisits C Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904 [TBL] [Abstract][Full Text] [Related]
15. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer. Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518 [TBL] [Abstract][Full Text] [Related]
16. [Treatment results with malignant cervical cancer in the Department of Medicine of the Friedrich Schiller University in Jena in 1965 to 1976. IV. An evaluation of primary radiological therapy via contact and percutaneous irradiation]. Sommer H; Kloetzer KH; Kob D; Nöschel H Zentralbl Gynakol; 1984; 106(7):467-72. PubMed ID: 6730769 [TBL] [Abstract][Full Text] [Related]
17. Postoperative radiation therapy for stage IB-IIB carcinoma of the cervix with poor prognostic factors. Uno T; Ito H; Itami J; Yasuda S; Isobe K; Hara R; Sato T; Minoura S; Shigematsu N; Kubo A Anticancer Res; 2000; 20(3B):2235-9. PubMed ID: 10928184 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic outcome and prognostic factors in the radiotherapy of recurrences of cervical carcinoma following surgery. Hille A; Weiss E; Hess CF Strahlenther Onkol; 2003 Nov; 179(11):742-7. PubMed ID: 14605743 [TBL] [Abstract][Full Text] [Related]
19. Hypoxic versus normoxic external-beam irradiation of cervical carcinoma combined with californium-252 neutron brachytherapy. Comparative treatment results of a 5-year randomized study. Tacev T; Vacek A; Ptácková B; Strnad V Strahlenther Onkol; 2005 May; 181(5):273-84. PubMed ID: 15900423 [TBL] [Abstract][Full Text] [Related]
20. Long-term results of high-dose rate brachytherapy in cervix cancer using a small number of fractions. Souhami L; Corns R; Duclos M; Portelance L; Bahoric B; Stanimir G Gynecol Oncol; 2005 May; 97(2):508-13. PubMed ID: 15863152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]